Condividi contenuti The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Aggiornato: 8 min 29 sec fa

Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test

Lun, 08/03/2015 - 14:20
BETHLEHEM, Pa., Aug. 3, 2015 -- (Healthcare Sales & Marketing Network) -- OraSure Technologies, Inc. (OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it has received a U.S. Food and Drug Administratio...
Diagnostics, FDA
OraSure Technologies, OraQuick Ebola, Ebola

PENTAX Europe GmbH Appoints Rainer Burkard President of Europe, Middle East and Africa Region (EMEA)

Lun, 08/03/2015 - 14:05
HAMBURG, Germany--(Healthcare Sales & Marketing Network)--PENTAX Europe GmbH, a division of HOYA Corporation, announced the appointment of Mr. Rainer Burkard to the position of President Europe, Middle East and Africa (EMEA) as of 1st August 2015. In this ...
Devices, Personnel
PENTAX Medical, HOYA Corporation, endoscopy

Xencor Appoints Yujiro S. Hata to Board of Directors

Ven, 07/31/2015 - 15:28
MONROVIA, Calif., July 31, 2015 -- (Healthcare Sales & Marketing Network) -- Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases...
Biopharmaceuticals, Personnel
Xencor, monoclonal antibody

Lombard Medical Acquires Endovascular Stent Graft Developer Altura Medical

Gio, 07/30/2015 - 23:40
Acquisition Expands Lombard Product Portfolio with Simple, Safe and Efficient Ultra-Low Profile Endovascular Stent Graft CE Mark in Place -- European Launch Scheduled for January IRVINE, Calif., July 30, 2015 -- (Healthcare Sales & Marketing Network...
Devices, Interventional, Mergers & Acquisitions
Lombard Medical, Altura Medical, stent graft, abdominal aortic aneurysm

Theragenics to Distribute the AccuBoost(R) Technology for Treatment of Early Stage Breast Cancer

Gio, 07/30/2015 - 23:35
Non-Invasive Brachytherapy Treatment Supplements Breast Conservation Therapy BUFORD, Ga.--(Healthcare Sales & Marketing Network)--Theragenics Corporation®, a medical device company serving the cancer treatment and surgical product markets, has reach...
Devices, Oncology, Distribution
Theragenics, Advanced Radiation Therapy, AccuBoost, brachytherapy, breast cancer

Abbott to Broaden Foundation in Structural Heart Therapies with Two Mitral Valve Transactions

Gio, 07/30/2015 - 23:29
Acquisition of Tendyne Holdings, Inc. to Expand Abbott's Mitral Valve Therapies In Separate Transaction, Abbott Has Provided Capital and Secured an Option to Purchase Cephea Valve Technologies ABBOTT PARK, Ill., July 30, 2015 -- (Healthcare Sales & M...
Devices, Interventional, Cardiology, Mergers & Acquisitions
Abbott, Tendyne, Bioprosthetic Mitral Valve, Cephea Valve Technologies

TapImmune Appoints John N. Bonfiglio, Ph.D., to its Board of Directors

Gio, 07/30/2015 - 15:42
Accomplished Biotech CEO is currently a Strategic Advisor to TapImmune SEATTLE, July 30, 2015 -- (Healthcare Sales & Marketing Network) -- TapImmune Inc. (TPIV) is pleased to announce the appointment of John N. Bonfiglio, Ph.D., MBA to its Board of Dir...
Biopharmaceuticals, Personnel
TapImmune, immunotherapy

Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics

Gio, 07/30/2015 - 15:40
CHICAGO, July 30, 2015 -- (Healthcare Sales & Marketing Network) -- Flexpoint Ford, a private equity firm focused on the healthcare and financial services sectors, today announced that it has entered into a partnership with Alan MacKenzie and Bryan Stuart...
Biopharmaceuticals, Personnel
Kastle Therapeutics

Japanese Approval Trial for Stress Urinary Incontinence Using Cytori Cell Therapy Announced

Gio, 07/30/2015 - 15:37
SAN DIEGO--(Healthcare Sales & Marketing Network)--Cytori Therapeutics, Inc. (CYTX) announced that it has recently been informed that a company-supported trial in Japan has received approval to begin enrollment from Japan MHLW (Ministry of Health, Labor an...
Regenerative Medicine, Urology, Oncology, Regulatory
Cytori Therapeutics, Cytori Cell Therapy, stress urinary incontinence

Corvida Medical Receives FDA 510(k) Clearance for Halo(TM) Closed System Transfer Device

Mer, 07/29/2015 - 15:52
CSTD Offers Smarter Solution for the Handling of Hazardous Drugs CORALVILLE, Iowa--(Healthcare Sales & Marketing Network)--Emerging medical device firm Corvida Medical has received a 510(k) clearance from the US Food and Drug Administration (FDA) to mar...
Devices, FDA
Corvida Medical, Closed System Transfer Device

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

Mer, 07/29/2015 - 15:49
300 Patients Enrolled at 42 Sites; Completion of Enrollment a Milestone in Timeline for U.S. Food and Drug Administration Approval of Stellarex(TM) COLORADO SPRINGS, Colo., July 29, 2015 -- (Healthcare Sales & Marketing Network) -- The Spectranetics Cor...
Devices, Interventional
Spectranetics, Stellarex, drug-coated balloon, peripheral arterial disease

Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations

Mer, 07/29/2015 - 15:45
Co-Founder of Xcellerex and Former Operations Leader at GE Healthcare Life Sciences to Lead Unum’s Clinical Manufacturing and Process Development Activities CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Unum Therapeutics, a company developin...
Biopharmaceuticals, Oncology, Personnel
Unum Therapeutics, Antibody-Coupled T-cell Receptor

EMBA Medical(TM) Limited Awarded CE Certificate for Hourglass(TM) Peripheral Embolization Plug

Mer, 07/29/2015 - 15:41
First Over-the-Wire Embolic Device Cleared for EU Commercial Release DUBLIN--(Healthcare Sales & Marketing Network)--EMBA Medical™ Limited announced today that the company has received CE certification for its revolutionary peripheral embolization devic...
Devices, Interventional, Regulatory
EMBA Medical, Hourglass, Peripheral Embolization Plug

Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film

Mer, 07/29/2015 - 15:15
Zuplenz is indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) Novel, oral soluble film technology provides convenient delivery a...
Biopharmaceuticals, Drug Delivery, Product Launch
Galena Biopharma, PharmFilm, Zuplenz, ondansetron

C2 Therapeutics Receives FDA 510(k) Clearance for the Coldplay Cryoballoon(TM) Full and Swipe Ablation Systems

Mer, 07/29/2015 - 15:10
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--C2 Therapeutics, a privately held company founded to improve treatment of precursors to esophageal cancer (Barrett’s Esophagus or BE), today announced US Food and Drug Administration (FDA) 510(k...
Devices, Gastroenterology, FDA
C2 Therapeutics, Barrett's Esophagus, Coldplay Cryoballoon

GlySure Appoints Roger Moody as Chief Executive Officer

Mar, 07/28/2015 - 15:06
ABINGDON, England--(Healthcare Sales & Marketing Network)--GlySure Limited, a leader in continuous glucose monitoring for critical care patients, today announced the appointment of Roger Moody as Chief Executive Officer. Mr. Moody, who has served as the Co...
Devices, Monitoring, Personnel
GlySure, continuous glucose monitor, glucose monitor

GlySure Appoints Roger Moody as Chief Executive Officer

Mar, 07/28/2015 - 14:39
ABINGDON, England--(Healthcare Sales & Marketing Network)--GlySure Limited, a leader in continuous glucose monitoring for critical care patients, today announced the appointment of Roger Moody as Chief Executive Officer. Mr. Moody, who has served as the Co...
Devices, Monitoring, Personnel
GlySure, continuous glucose monitor, glucose monitor

U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A

Mar, 07/28/2015 - 14:35
rVIII-SingleChain underscores CSL Behring's deep commitment to developing and delivering specialty biotherapies that improve the well-being of patients with serious diseases KING OF PRUSSIA, Pa., July 28, 2015 -- (Healthcare Sales & Marketing Network) ...
Biopharmaceuticals, FDA
CSL Behring, factor VIII, Hemophilia

Kailos Genetics Hires Cheri Walker as Chief Financial Officer

Lun, 07/27/2015 - 20:17
Walker to support corporate strategic development following the launch of Praxis, a consumer-directed gene-based test HUNTSVILLE, Ala.--(Healthcare Sales & Marketing Network)--Kailos Genetics, a personalized medicine information company offering leading...
Diagnostics, Personalized Medicine, Personnel
Kailos Genetics, TargetRich

Lenox Hill Hospital Using New Device to Treat Aneurysms

Lun, 07/27/2015 - 15:33
NEW YORK--(Healthcare Sales & Marketing Network)--Lenox Hill Hospital is 1 of 20 centers in the United States participating in a clinical trial evaluating the safety and efficacy of a new device to treat brain aneurysms without traditional surgery. “In ...
Devices, Interventional
Lenox Hill Hospital, Lenox Bypass, cerebral aneurysm

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong